# Effect of Switching to Certican® in Viremia of Hepatitis C Virus in Adult Renal Allograft Recipients

> **NCT01469884** · PHASE4 · COMPLETED · sponsor: **Irmandade Santa Casa de Misericórdia de Porto Alegre** · enrollment: 30 (actual)

## Conditions studied

- Renal Allograft
- Hepatitis C

## Interventions

- **DRUG:** Everolimus
- **DRUG:** Cyclosporine
- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT01469884
- **Lead sponsor:** Irmandade Santa Casa de Misericórdia de Porto Alegre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2015-04-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01469884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01469884, "Effect of Switching to Certican® in Viremia of Hepatitis C Virus in Adult Renal Allograft Recipients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01469884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*